| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/16/2023 | — | Raymond James | Downgrades | Strong Buy → Market Perform | |
| 11/10/2023 | 287.6% | Raymond James | $20 → $5 | Maintains | Strong Buy |
| 11/10/2023 | — | JP Morgan | Downgrades | Neutral → Underweight | |
| 10/18/2023 | 675.19% | JP Morgan | $14 → $10 | Maintains | Neutral |
| 10/04/2023 | 287.6% | Truist Securities | $10 → $5 | Maintains | Sell |
| 10/03/2023 | 1450.39% | Raymond James | $25 → $20 | Maintains | Strong Buy |
| 10/03/2023 | 675.19% | RBC Capital | → $10 | Reiterates | Sector Perform → Sector Perform |
| 07/11/2023 | 1450.39% | Citigroup | $32 → $20 | Maintains | Buy |
| 05/15/2023 | 675.19% | RBC Capital | $32 → $10 | Maintains | Sector Perform |
| 05/05/2023 | 1837.98% | Raymond James | $55 → $25 | Maintains | Strong Buy |
| 05/04/2023 | 675.19% | Truist Securities | $40 → $10 | Downgrades | Buy → Sell |
| 04/05/2023 | 2380.62% | Citigroup | $62 → $32 | Maintains | Buy |
| 04/05/2023 | 4163.57% | Raymond James | $65 → $55 | Maintains | Strong Buy |
| 04/04/2023 | 3000.78% | Truist Securities | $70 → $40 | Maintains | Buy |
| 04/04/2023 | 2380.62% | Citigroup | $62 → $32 | Maintains | Buy |
| 03/03/2023 | 3310.85% | JP Morgan | $61 → $44 | Maintains | Neutral |
| 03/02/2023 | 4938.76% | Raymond James | $80 → $65 | Maintains | Strong Buy |
| 02/01/2023 | 5326.36% | Truist Securities | $80 → $70 | Maintains | Buy |
| 11/29/2022 | 4783.72% | RBC Capital | $76 → $63 | Maintains | Sector Perform |
| 10/20/2022 | 4551.16% | JP Morgan | $66 → $60 | Maintains | Neutral |
| 10/18/2022 | 6101.55% | Raymond James | → $80 | Upgrades | Outperform → Strong Buy |
| 10/14/2022 | 4706.2% | Citigroup | $79 → $62 | Upgrades | Neutral → Buy |
| 09/15/2022 | 6101.55% | Raymond James | → $80 | Upgrades | Market Perform → Outperform |
| 08/19/2022 | 5791.47% | RBC Capital | $78 → $76 | Downgrades | Outperform → Sector Perform |
| 07/20/2022 | 5403.88% | JP Morgan | $70 → $71 | Maintains | Neutral |
| 05/13/2022 | 5946.51% | RBC Capital | $85 → $78 | Maintains | Outperform |
| 04/19/2022 | 5868.99% | JP Morgan | $76 → $77 | Maintains | Neutral |
| 04/05/2022 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 03/29/2022 | 7651.94% | Truist Securities | → $100 | Initiates Coverage On | → Buy |
| 03/07/2022 | 6489.15% | RBC Capital | $78 → $85 | Maintains | Outperform |
| 03/02/2022 | 5791.47% | JP Morgan | $70 → $76 | Maintains | Neutral |
| 01/04/2022 | 5868.99% | Raymond James | $75 → $77 | Maintains | Outperform |
| 12/09/2021 | 5868.99% | JP Morgan | → $77 | Downgrades | Overweight → Neutral |
| 11/05/2021 | 5713.95% | Raymond James | $57 → $75 | Maintains | Outperform |
| 10/18/2021 | 6101.55% | Barclays | $67 → $80 | Maintains | Overweight |
| 10/18/2021 | 5713.95% | RBC Capital | $60 → $75 | Maintains | Outperform |
| 10/05/2021 | 4318.6% | Raymond James | → $57 | Downgrades | Strong Buy → Outperform |
| 09/07/2021 | 4783.72% | JP Morgan | → $63 | Initiates Coverage On | → Overweight |
| 09/02/2021 | 4086.05% | Goldman Sachs | → $54 | Initiates Coverage On | → Neutral |
| 06/07/2021 | 4938.76% | Barclays | $64 → $65 | Maintains | Overweight |
| 02/25/2021 | 4318.6% | Raymond James | $52 → $57 | Maintains | Strong Buy |
| 01/08/2021 | 3931.01% | Raymond James | $48 → $52 | Maintains | Strong Buy |
| 11/05/2020 | 3620.93% | Raymond James | $44 → $48 | Maintains | Strong Buy |
| 10/08/2020 | 3310.85% | Raymond James | $42 → $44 | Maintains | Strong Buy |
| 06/24/2020 | 3155.81% | Raymond James | $38 → $42 | Maintains | Strong Buy |
| 04/30/2020 | 2845.74% | Raymond James | $36 → $38 | Maintains | Strong Buy |
| 04/24/2020 | 2613.18% | Citigroup | $40 → $35 | Maintains | Neutral |
| 03/18/2020 | 3000.78% | Raymond James | → $40 | Upgrades | Outperform → Strong Buy |
| 02/13/2020 | 3000.78% | Citigroup | $34 → $40 | Downgrades | Buy → Neutral |
What is the target price for Enviva (EVA)?
The latest price target for Enviva (NYSE: EVA) was reported by Raymond James on November 16, 2023. The analyst firm set a price target for $0.00 expecting EVA to fall to within 12 months (a possible -100.00% downside). 19 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Enviva (EVA)?
The latest analyst rating for Enviva (NYSE: EVA) was provided by Raymond James, and Enviva downgraded their market perform rating.
When is the next analyst rating going to be posted or updated for Enviva (EVA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Enviva, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Enviva was filed on November 16, 2023 so you should expect the next rating to be made available sometime around November 16, 2024.
Is the Analyst Rating Enviva (EVA) correct?
While ratings are subjective and will change, the latest Enviva (EVA) rating was a downgraded with a price target of $0.00 to $0.00. The current price Enviva (EVA) is trading at is $1.29, which is out of the analyst's predicted range.